Comparative Efficacy of a Toothpaste That Reduces Plaque and Gingivitis
This study has been completed.
Sponsor:
Colgate Palmolive
Information provided by:
Colgate Palmolive
ClinicalTrials.gov Identifier:
NCT00926328
First received: September 26, 2008
Last updated: June 10, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
The objective of this study is to evaluate the performance of two toothpastes in controlling established gingivitis and dental plaque in adults.
| Condition | Intervention | Phase |
|---|---|---|
|
Gingivitis |
Drug: Triclosan, fluoride Drug: Fluoride |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | Comparative Efficacy of a Toothpaste That Reduces Plaque and Gingivitis |
Resource links provided by NLM:
Further study details as provided by Colgate Palmolive:
Primary Outcome Measures:
- Gingivitis Index [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Units on a scale 0 to 3 (0 = no inflammation ,
1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing.
3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)
- Plaque Index [ Time Frame: 6 Months ] [ Designated as safety issue: No ]Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)
| Enrollment: | 94 |
| Study Start Date: | June 2007 |
| Study Completion Date: | December 2007 |
| Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: A -Experimental toothpaste
triclosan/copolymer/fluoride toothpaste
|
Drug: Triclosan, fluoride
Six Month study, brush twice daily
Other Name: Colgate Total Advanced Freshening toothpaste
|
|
Placebo Comparator: B - control toothpaste
sodium fluoride only toothpaste (placebo)
|
Drug: Fluoride
twice daily usage
Other Name: Crest Cavity Protection toothpaste
|
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Availability for the six-month duration of the study.
- Good general health.
- Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
- Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
- Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein Plaque Index (Turesky Modification).
- Signed Informed Consent Form.
Exclusion Criteria:
- Presence of orthodontic bands.
- Presence of partial removable dentures.
- Tumor(s) of the soft or hard tissues of the oral cavity.
- Advanced periodontal disease (purulent exudate,tooth mobility, and/or extensive loss of
- periodontal attachment or alveolar bone).
- Five or more carious lesions requiring immediate restorative treatment.
- Use of antibiotics any time during the one month prior to entry into the study.
- Participation in any other clinical study or test panel within the one month prior to entry
- into the study.
- Pregnant women or women who are breast feeding.
- Receive a dental prophylaxis in the past two weeks prior to baseline examinations.
- History of allergic to personal care/consumer products or their ingredients.
- Taking any prescription medicines. That might interfere with the study outcome.
- Individuals with an existing medical condition which prohibits them from not eating or drinking for periods up to 4 hours.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | William DeVizio/VP - Clinical Research, Colgate Palmolive |
| ClinicalTrials.gov Identifier: | NCT00926328 History of Changes |
| Other Study ID Numbers: | CRO-0507-PL-SP-CT-BS |
| Study First Received: | September 26, 2008 |
| Results First Received: | September 26, 2008 |
| Last Updated: | June 10, 2011 |
| Health Authority: | United States: Food and Drug Administration |
Keywords provided by Colgate Palmolive:
|
Gingivitis and Plaque |
Additional relevant MeSH terms:
|
Gingivitis Gingival Diseases Periodontal Diseases Mouth Diseases Stomatognathic Diseases Fluorides Triclosan Hexachlorophene Cariostatic Agents Protective Agents |
Physiological Effects of Drugs Pharmacologic Actions Fatty Acid Synthesis Inhibitors Hypolipidemic Agents Antimetabolites Molecular Mechanisms of Pharmacological Action Anti-Infective Agents, Local Anti-Infective Agents Therapeutic Uses Lipid Regulating Agents |
ClinicalTrials.gov processed this record on May 23, 2013